| Date Filed | Type | Description |
| 07/05/2023 |
4
| Longpre Lara (Chief Development Officer) has filed a Form 4 on Mirum Pharmaceuticals, Inc.|
Txns:
| Sold 1,004 shares
@ $25.6466, valued at
$25.7k
|
|
| 05/19/2023 |
4
| Longpre Lara (Chief Development Officer) has filed a Form 4 on Mirum Pharmaceuticals, Inc.|
Txns:
| Granted 684 shares
@ $16.9235, valued at
$11.6k
|
|
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/14/2022 |
4
| Longpre Lara (Chief Development Officer) has filed a Form 4 on Mirum Pharmaceuticals, Inc.|
Txns:
| Granted 82 shares
@ $17.051, valued at
$1.4k
|
|
| 05/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/07/2022 |
4
| Longpre Lara (Chief Development Officer) has filed a Form 4 on Mirum Pharmaceuticals, Inc.|
Txns:
| Granted 10,000 shares
@ $0
Granted 60,000 options to buy
@ $15.87, valued at
$952.2k
|
|
| 10/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/08/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 01/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/12/2020 |
4
| Longpre Lara (Chief Development Officer) has filed a Form 4 on Mirum Pharmaceuticals, Inc.|
Txns:
| Granted 822 shares
@ $15.266, valued at
$12.5k
|
|
| 01/14/2020 |
4
| Longpre Lara (Chief Development Officer) has filed a Form 4 on Mirum Pharmaceuticals, Inc.|
Txns:
| Granted 52,000 options to buy
@ $19.24, valued at
$1M
|
|
| 07/17/2019 |
3
| Longpre Lara (Chief Development Officer) has filed a Form 3 on Mirum Pharmaceuticals, Inc. |